Drug intelligence / Profile preview

calcium carbonate + cholecalciferol (MTI Medical)

Development stage: Unknown
Lead developer: MTI Medical
Modality: Small Molecules
Administration: Oral

Overview

Zocobin Plus Tablet is a dietary supplement developed by MTI Medical, containing a combination of calcium carbonate (800mg) and vitamin D3 (cholecalciferol, 400IU). It is indicated for the prevention and treatment of calcium and vitamin D deficiencies, which are essential for maintaining bone density and preventing conditions such as osteoporosis. Calcium carbonate provides a source of elemental calcium necessary for bone mineralization, while vitamin D3 enhances the intestinal absorption of calcium and regulates calcium-phosphorus homeostasis. The product is marketed in an oral tablet formulation.

Brand names: Zocobin Plus Tablet
Other names: Zocobin Plus

Targets

VDR (Vitamin D receptor)

Beyond the preview

Go deeper on calcium carbonate + cholecalciferol (MTI Medical).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on calcium carbonate + cholecalciferol (MTI Medical).

Explore the full profile